Page 545 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 545

CHAPTER 24  Tumors of the Respiratory System  523


             375.   Jemal A, Center MM, DeSantis C, et al.: Global patterns of cancer     381.   Maekawa N, Konnai S, Takagi S, et al.: A canine chimeric mono-
               incidence and mortality rates and trends,  Cancer Epidemiol Bio-  clonal antibody targeting PD-L1 and its clinical efficacy in canine
               markers Prev 19:1893–1907, 2010.                      oral malignant melanoma or undifferentiated sarcoma,  Sci Rep
  VetBooks.ir    376.   Valaitis J, Warren S, Gamble D: Increasing incidence of adenocar-    382.   Hartley  G, Faulhaber E, Caldwell A, et  al.: Immune regulation
                                                                     7:8951, 2017.
               cinoma of the lung, Cancer 47:1042–1046, 1981.
             377.   Westra WH, Slebos RJ, Offerhaus GJ, et al.: K-ras oncogene activa-
               tion in lung adenocarcinomas from former smokers. Evidence that   of canine tumour and macrophage PD-L1 expression, Vet Comp
                                                                     Oncol 15:534–549, 2017.
               K-ras mutations are an early and irreversible event in the develop-    383.   Shosu K, Sakurai M, Inoue K, et al.: Programmed cell death ligand
               ment of adenocarcinoma of the lung, Cancer 72:432–438, 1993.  1 expression in canine cancer. In Vivo 30:195–204, 2016.
             378.   Brahmer JR, Govindan R, Anders RA, et al.: The Society for Immu-    384.   Postorino NC, Wheeler SL, Park RD, et al.: A syndrome resem-
               notherapy of Cancer consensus statement on immunotherapy for   bling lymphomatoid granulomatosis in the dog, J Vet Intern Med
               the treatment of non-small cell lung cancer (NSCLC), J Immuno-  3:15–19, 1989.
               ther Cancer 6:75, 2018.                             385.   Shimazaki T, Nagata M, Goto-Koshino Y, et al.: A case of canine
             379.   Maekawa N, Konnai S, Ikebuchi R, et al.: Expression of PD-L1   lymphomatoid granulomatosis with cutaneous lesions, J Vet Med
               on canine tumor cells and enhancement of IFN-gamma produc-  Sci 72:1061–1067, 2010.
               tion from tumor-infiltrating cells by PD-L1 blockade, PLoS One     386.   Needle DB, Hollinger C, Singer LM, et al.: Pathology in practice.
               9:e98415, 2014.                                       Lymphomatoid granulomatosis of lung tissue and mediastinal
             380.   Maekawa N, Konnai S, Okagawa T, et al.: Immunohistochemi-  lymph node in a dog, J Am Vet Med Assoc 247:1113–1116, 2015.
               cal analysis of PD-L1 expression in canine malignant cancers and     387.   Berry CR, Moore PF, Thomas WP, et al.: Pulmonary lymphoma-
               PD-1 expression on lymphocytes in canine oral melanoma, PLoS   toid granulomatosis in seven dogs (1976-1987), J Vet Intern Med
               One 11:e0157176, 2016.                                4:157–166, 1990.
   540   541   542   543   544   545   546   547   548   549   550